Leif Göran Kvist
Nessuna posizione attualmente
Storia della carriera di Leif Göran Kvist
Precedenti posizioni note di Leif Göran Kvist
Società | Posizione | Inizio | Fine |
---|---|---|---|
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Presidente | - | - |
Fondatore | - | - | |
QP Support AB | Presidente | - | - |
Fondatore | - | - | |
ACUCORT AB | Direttore/Membro del Consiglio | 11/07/2013 | - |
TQ Kvalitetskonsult AB
TQ Kvalitetskonsult AB Miscellaneous Commercial ServicesCommercial Services TQ Kvalitetskonsult AB provides science and technology research and development services. The private company is based in Morarp, Sweden. | Amministratore Delegato | - | - |
Presidente | - | - | |
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Presidente | 01/01/2003 | - |
Fondatore | 01/01/2003 | - |
Formazione di Leif Göran Kvist
University of Uppsala | Undergraduate Degree |
Statistiche
Distribuzione geografica
Svezia | 7 |
Posizioni
Chairman | 4 |
Founder | 3 |
Director/Board Member | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ACUCORT AB | Health Technology |
Aziende private | 4 |
---|---|
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Health Technology |
TQ Kvalitetskonsult AB
TQ Kvalitetskonsult AB Miscellaneous Commercial ServicesCommercial Services TQ Kvalitetskonsult AB provides science and technology research and development services. The private company is based in Morarp, Sweden. | Commercial Services |
QP Support AB | |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Leif Göran Kvist
- Esperienza